Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes. - Wikidata - awgldk - TriplyDB

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.

http://www.wikidata.org/entity/Q41422799

about

YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer's disease and other tauopathies.Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis.Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome.Body fluid biomarkers for multiple sclerosis--the long road to clinical application.Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.Neuronal Pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer's disease spectrum.The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases.Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis.Genes differentially expressed by methylprednisolone in vivo in CD4 T lymphocytes from multiple sclerosis patients: potential biomarkers.Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.Pharmacodynamic effects of daclizumab in the intrathecal compartment.Neurofilament light chain predicts disease activity in relapsing-remitting MS.Serum neurofilament light chain in relapsing-remitting MS: Unchaining disease activity prediction?Fluid biomarker and electrophysiological outcome measures for progressive MS trials.Neuron-glia interaction as a possible pathophysiological mechanism of bipolar disorder.Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.Science is 1% inspiration and 99% biomarkers.[Cerebrospinal fluid diagnostics in multiple sclerosis].Novel CSF biomarkers to discriminate FTLD and its pathological subtypes CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease

P2860

Q33784904-30CE9ACD-E6F2-419D-B46B-31C7DD9D54DC Q35848490-77783BB4-FE0F-4B9D-9A11-05D1FB194B57 Q37416267-C32FE459-22E1-4277-8090-921801F609C4 Q38590773-F4EB7598-F2E8-4CD6-AD64-EE29B7803145 Q38802998-06A5EE0D-52E7-4939-AC94-8B2FF241453D Q38839061-347F3B3E-F45E-4E27-BB93-58E4A989659A Q38910574-97F629B3-240D-4BC7-BD18-129E46442316 Q38915171-98FE8E1C-0D3D-4893-A7EF-0F074C6F6C44 Q38984981-004B49AC-F512-4A44-99FD-9CFA6C744455 Q39027028-79D698A5-FD7E-483F-A059-A737AB4CB84B Q39349492-D6E87EBB-A126-42FB-B817-AD75587242F4 Q40027938-B215D930-868E-4E9E-A349-CB6B20FB6747 Q40962441-1F61295D-3CA1-4686-BFB2-7DAFD70C821C Q47138197-28D83729-0388-4DEF-A686-86A967DE36CC Q47148522-270E3999-AB84-4CD1-9434-580C2B2CE084 Q47638443-874DD573-DA5E-4E94-8C6A-FA9D330CE6DE Q48137161-667C9EE8-54C0-48E1-80BD-C73864833F66 Q48910491-F5FC25CB-BE35-485E-86F2-B94B18BE535A Q50984144-1D04E755-8DF4-43E8-AF80-00C0F7F6D89C Q52847541-583DFF9B-51EE-4506-A8C7-82FD675D75B5 Q57822410-E1415432-5D9E-4145-996A-21375770C2B1 Q58697672-D5481529-0568-489B-A4D2-DB764FE151E9

P2860

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.

http://www.wikidata.org/entity/Q41422799

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.

@en

type

label

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.

@en

prefLabel

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.

@en

P1433

Q41422799-7F4A75E5-E34D-4423-A219-F261567096A1

P1476

Q41422799-9F103C02-F6F1-47D1-A052-62A8103B615C

P2093

Q41422799-05F02FA4-CBFB-4261-A690-E7C819293BEE

Q41422799-0BCB170C-583F-4C13-9CD3-F7FB58CFC6A7

Q41422799-0C5BD69A-B175-4FB1-8D3D-B8D9D0CC7C33

Q41422799-0CAC7982-DF78-44CF-8993-D14422F3C321

Q41422799-1965A1B2-6D76-40B4-BEF8-A329DE2D8FC0

Q41422799-21BB1715-9F20-4CB7-AF56-390EB862363D

Q41422799-228842B7-DD4D-4C83-9420-40D18DE09F69

Q41422799-281A0E04-DF6D-4B15-8D25-AC42A58FFD2D

Q41422799-29DCF45B-AD97-4291-861B-31ED25E3A4C5

Q41422799-412F06A8-D767-427C-98E3-1A39CE44979F

P2860

Q41422799-03FD5919-55B0-4F66-9DAA-7768DAB32503

Q41422799-074373DC-393B-4E87-8FA2-D285DE005357

Q41422799-0955DEE8-1EAA-486C-9787-F757C68CE7B4

Q41422799-11AC0630-DA04-4EC9-AD7F-C6D0591A1D97

Q41422799-19A96756-D591-4E79-8159-4B4732CEE7E1

Q41422799-1C529319-8D82-4A66-B0C7-6342BAA29626

Q41422799-2157D0C8-C8B6-4B0A-8141-04102F017938

Q41422799-333142F8-DC8D-4125-B687-2B4E8920E184

Q41422799-3886ED80-44D8-4900-B6ED-A2FFB902C9E2

Q41422799-4D572DD7-2ACC-4597-8B78-D00A4A30C3F4

P304

Q41422799-03B9A1EA-F9C0-44D4-9777-6601F283609E

P31

Q41422799-5B1969E6-D928-4453-B1C1-7D24343A370B

P356

Q41422799-632BD54B-FBEA-4069-AF70-27C3158F3559

P407

Q41422799-41E47C13-7F1B-4283-9AAA-6E8F134095D1

P433

Q41422799-53783322-AFD6-4A50-8264-422007196DEA

P478

Q41422799-7BED2DEA-9636-476F-9CF4-1F16C5588FBE

P50

Q41422799-1FBC3ADD-A17C-476F-BCE5-63DB632BBF81

Q41422799-271E7E3A-7A8B-4D0F-8305-360280E6BC77

Q41422799-2A4A0B4E-1FBF-44CF-9004-F5B024627C73

Q41422799-2A744CFE-6240-4B7B-97C1-D6D5A88A89B1

Q41422799-339AF3CE-CCC2-4672-9FCF-C8620F0A7B3F

Q41422799-349898FD-F9EC-4615-BA50-2FC724695BA7

Q41422799-3B962808-A9CD-48A4-BA6E-FE25D8DF4424

Q41422799-3DD2A512-339E-4C3E-84E8-7EC37131CEDC

Q41422799-4AF50B02-D839-4E58-9DD7-18B3A01790BF

Q41422799-71E100FA-5294-482D-9FC5-9DDDD034AB7B

P577

Q41422799-48207043-30F3-47A9-BC76-64AC75903CDE

P5875

Q41422799-3971023B-5950-40C9-9E42-D77541C15313

P698

Q41422799-9E337138-3966-43F4-8BD1-43F0615B294C

P921

Q41422799-C5E539F1-1757-49AB-8825-CA8284B2B70A

P356

P1433

P1476

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.

@en

P2093

Albert Saiz

http://www.w3.org/2001/XMLSchema#string

Alex Rovira

http://www.w3.org/2001/XMLSchema#string

Christian Enzinger

http://www.w3.org/2001/XMLSchema#string

Clara de Andrés

http://www.w3.org/2001/XMLSchema#string

David Brassat

http://www.w3.org/2001/XMLSchema#string

Denisa Zimova

http://www.w3.org/2001/XMLSchema#string

Ester Cantó

http://www.w3.org/2001/XMLSchema#string

Eulalia Rodríguez-Martín

http://www.w3.org/2001/XMLSchema#string

Ewa Papuc

http://www.w3.org/2001/XMLSchema#string

Florian Deisenhammer

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Identification of a novel acidic mammalian chitinase distinct from chitotriosidase

The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress

Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages

Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins

Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation

Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage

Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease

Blood monocytes consist of two principal subsets with distinct migratory properties

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.

P304

918-931

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWV017

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 4

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

Daniela Galimberti

Ferran Reverter

Ramil Nurtdinov

P577

2015-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272512107

http://www.w3.org/2001/XMLSchema#string

P698

25688078

http://www.w3.org/2001/XMLSchema#string

P921